CVS Health (CVS) PT Raised to $77 at Morgan Stanley
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $97.16 +2.28%
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Morgan Stanley analyst Ricky Goldwasser raised the price target on CVS Health (NYSE: CVS) to $77.00 (from $71.00) while maintaining a Overweight rating.
You May Also Be Interested In
- CVS Health (CVS) PT Raised to $118 at JPMorgan
- LG Electronics India (LGEL:IN) PT Raised to INR1,815 at ICICI Securities
- Apollo Hospitals (APLH:IN) PT Raised to INR8,500 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
